Treatment of plasmablastic lymphoma with multiple organ involvement

Liang, Rong; Wang, Zhe; Chen, Xiequn; Bai, Qiang-xian

doi:10.11622/smedj.2014184

Cited by 5 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The management of lymphoma of the breast is controversial 13 . Secondary lymphoma of the breast is commonly associated with multiorgan involvement 14 . Treatment options include mainly combination chemotherapy with or without radiotherapy or at times radiotherapy alone 15…”

Section: Discussionmentioning

confidence: 99%

T‐cell non‐Hodgkin’s lymphoma of both breasts: An uncommon presentation of a common disease

Sereke

Oriekot

Mboizi

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

T‐cell non‐Hodgkin’s lymphoma of both breasts: An uncommon presentation of a common disease

Sereke

Oriekot

Mboizi

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…Since the first description of PBL, in 1997, by Delecluse et al [7], the spectrum of PBL involvement of various organs has widened. Various sites from where it has been reported include skin [8], breast [9], gastrointestinal [10], central nervous system [11], male genitourinary system, and bone [12]. It is rarely found in children [13].…”

Section: Discussionmentioning

confidence: 99%

Primary Central Nervous System Effusion Plasmablastic Lymphoma in Immunocompromised Patient: A Rare Phenomenon

Singh

Belurkar

Bishnu

et al. 2018

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Primary effusion lymphoma (PEL) is an aggressive neoplasm with a high rate of fatality. PEL cells are known to have morphological diversities, which range from immunoblastic or plasmablastic to anaplastic. Most of these cases are described in immunocompromised as well as immunocompetent patients. Plasmablastic lymphoma remains a diagnostic challenge, especially when encountered with the presentation as PEL. In spite of therapeutic advances, PEL remains an aggressive disease with a high rate of fatality. We describe one case of this extremely rare neoplasm in an immunocompromised patient presenting in the form of primary central nervous system effusion plasmablastic lymphoma. To the best of our knowledge, this is the first case ever been reported in the literature.

show abstract

“…First, there were multiple focal lesions in a wide variety of locations, 15 but without lungs, liver or bone infiltration, which are the typical sites of metastases. Also, the soft tissue mass located at the chest wall respected adjacent ribs, which was a remarkable finding in such an aggressive disease.…”

Section: Discussionmentioning

confidence: 99%

What is that? HIV-negative plasmablastic lymphoma with intramuscular masses

Alandete¹,

Monedero²,

Meseguer³

et al. 2016

BJR|case reports

View full text Add to dashboard Cite

Plasmablastic lymphoma is a relatively new clinical entity described as a distinct subtype of diffuse large B-cell lymphoma, although in the last decade several case reports and series have been published. This case is presented because of its rarity, as this pathology is rare in immunocompetent patients and intramuscular masses are present. We report the case of a 63-year-old male with no significant clinical background. He was referred to the emergency department of our hospital with a 10-day history of pain on the left side of the chest that was described as burning and spreading to the right side. On physical examination, he had no fever or recent weight loss. The abdomen was soft and non-distended, and no peritoneal signs were present but he had three palpable masses located in the soft tissues of the breast, right gluteal region and left leg. Histological examination of the biopsy specimens disclosed the diagnosis of plasmablastic lymphoma. To our knowledge, this will be the second case report referring to intramuscular masses in the English language literature.

show abstract

Treatment of plasmablastic lymphoma with multiple organ involvement

Cited by 5 publications

References 10 publications

T‐cell non‐Hodgkin’s lymphoma of both breasts: An uncommon presentation of a common disease

T‐cell non‐Hodgkin’s lymphoma of both breasts: An uncommon presentation of a common disease

Primary Central Nervous System Effusion Plasmablastic Lymphoma in Immunocompromised Patient: A Rare Phenomenon

What is that? HIV-negative plasmablastic lymphoma with intramuscular masses

Contact Info

Product

Resources

About